As expected, in the present work, in vitro models showed that piceatannol or epicatechin can inhibit proliferation and TNF-α-induced inflammatory response of RA-FLS, and induced cell cycle arrest and apoptosis, validating the promising roles of piceatannol and epicatechin in RA treatment. This evidence concerns the gene TNF and rheumatoid arthritis.